Resources | Medicines Discovery Catapult

Discovery Science & Technology
- - - Establishing patient-relevant testing models and new technologies to advance drug discovery
    - Focus Areas
    - Complex Cell Models
    - Target Engagement & Validation
    - Biomarkers for Precision Medicine
    - Drug Delivery
    - Pre-clinical Imaging
  - - Technology Innovation
    - Mass Spectrometry
Informatics
- - - Discovering and connecting data to build new algorithms, AI and machine learning approaches
    - Analysis of Chemical Space
    - Drug Combinations
    - Drug Efficacy & Safety
    - Drug Repurposing
    - Druggability and Target Validation
Virtual R&D
- - - Leveraging the UK’s renowned leadership in drug discovery – a modern approach to R&D
      
      Virtual R&D is the delivery of medicines R&D using multiple best-in-class partners, ensuring the critical value-based experiments are done by the right people, data is captured, and IP-estate is secured.
    - Expert Advice Service
Syndicates
- - - Enabling patient-centred drug discovery – a collective approach to R&D
      
      Syndicates are a new, shared resource model for patient-centred R&D. They are disease-focussed consortia, anchored by the leading medical research charity in partnership with us.
    - Psychiatry Consortium
Samples & Data
- - - Brokering easier access to consented patient data and samples
      
      The UK has millions of samples and billions of data points collected from UK patients who have agreed that their samples and data can be used for research. But small UK medical research companies struggle to access them.
    - Tissue Samples
    - Clinical Data

Newer posts

Establishing patient-relevant testing models and new technologies to advance drug discovery

Focus Areas

Technology Innovation

Discovering and connecting data to build new algorithms, AI and machine learning approaches

Leveraging the UK’s renowned leadership in drug discovery – a modern approach to R&D

Enabling patient-centred drug discovery – a collective approach to R&D

Brokering easier access to consented patient data and samples